Skip to main content
. 2021 Feb 3;15:1180. doi: 10.3332/ecancer.2021.1180

Table 3. Cancer staging comparison Apr 2020 to Sep 2020 versus Oct 2019 to Mar 2020. Number of cases and percentage early versus late stage.

Oct 2019 to Mar 2020 April 2020 to Sept 2020
Tumour group Early stage Late stage Early stage Late stage
Breast 162 71 121 54
Colorectal 53 116 20 57
Lung 98 140 61 114
Prostate 259 139 84 48
Overall 572 466 286 273
Oct 2019 to Mar 2020 April 2020 to Sept 2020 Variance
(Late stage)
Tumour group Early stage Late stage Early stage Late stage
Breast 69.5% 30.5% 69.1% 30.9% +0.4%
Colorectal 31.4% 68.6% 26.0% 74.0% +5.4%
Lung 41.2% 58.8% 34.9% 65.1% +6.3%
Prostate 65.1% 34.9% 63.6% 36.4% +1.4%
Overall 55.1% 44.9% 51.2% 48.8% +3.9%